The polypeptide analgesic compounds APCH3 (a TRPV1 receptor inhibitor) and PT1 (a P2X3 receptor inhibitor) were shown not to act on the cardiovascular system or respiratory system when given either as single or multiple doses in mice. The low molecular weight compound sevanol (an ASIC3 receptor inhibitor) had no effect on the cardiovascular system, but prolonged use for 14 days affected measures of the respiratory system, significantly increasing respiratory rate and peak expiratory flow rate.
Similar content being viewed by others
References
Guidelines for Preclinical Studies of Medicines [in Russian], Grif i K, Moscow (2012), part 1.
Y. A. Andreev, A. A. Vassilevski, S. A. Kozlov, et al., Recent Pat. Inflam. Allergy Drug Discov., 6, 35 – 45 (2012).
N. V. Kabanova, A. A. Vassilevski, O. A. Rogachevskaja, et al., Biochim. Biophys. Acta., 1818, 2868 – 2875 (2012).
H. Gunosewoyo and M. Kassiou, Expert Opin. Ther. Pat., 20, 625 – 646 (2010).
S. A. Kozlov, Y. A. Andreev, A. N. Murashev, et al., Rus. J. Bioorganic Chem., 35(6), 711 – 719 (2009).
Y. A. Andreev, S. A. Kozlov, Y. V. Korolkova, et al., Mar. Drugs, 11(12), 5100 – 5115 (2013).
M. A. Dubinnyi, D. I. Osmakov, S. G. Koshelev, et al., J. Biol. Chem., 287, 32993 – 33000 (2012).
D. I. Osmakov, S. A. Kozlov, Y. A. Andreev, et al., J. Biol. Chem., 288, 23116 – 23127 (2013).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 7, pp. 9 – 11, July, 2018.
Rights and permissions
About this article
Cite this article
Palikova, Y.A., Skobtsova, L.A., Palikov, V.A. et al. Effects of Novel Potential Analgesic Compounds on the Cardiovascular and Respiratory Systems. Pharm Chem J 52, 593–595 (2018). https://doi.org/10.1007/s11094-018-1865-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-018-1865-7